Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
0.3%
1w
0.8%
1m
11.6%
3m
12.1%
6m
3.2%
1y
13.2%
5y
11.0%
10y
21.3%
all
25.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 27,907 0.3%
24,620
28,582
Company Overview

Sales
6,929 Cr
Growth: 8.3%
Profit after Tax
1,552 Cr
Growth: 1.8%
Large Cap
59,301 Cr
P/E: 38.2x
Industry P/E: 32.3x
Fundamentals

Sales (Cr) ₹ 6,929
Growth 8.3%
EBITDA 27.3%
P/S 8.6x
Dividend 1.4%
P/E 38.2x
Book Value ₹ 2,247
PEG Ratio 4.6x
ROE 31.4%
P/B 12.4x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.
Investors (50)
Followers (16)